新型冠状病毒肺炎疫情下生殖医学的新问题与挑战  

Emerging questions and challenges of COVID-19 on reproductive health

作　　者：李蓉[1] 杨菁[2] 李红钢 王媛媛[1] 程丹[2] 段鹏 吴庚香[2] 尹太郎[2] 熊承良[3] 乔杰[1] Li Rong;Yang Jing;Li Honggang;Wang Yuanyuan;Cheng Dan;Duan Peng;Wu Gengxiang;Yin Tailang;Xiong Chengliang;Qiao Jie(Reproductive Medical Center,Peking University Third Hospital,Beijing 100191,China;Reproductive Medical Center,Renmin Hospital of Wuhan University,Wuhan 430060,China;Institute of Reproductive Health,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China)

机构地区：[1]北京大学第三医院生殖医学中心,100191 [2]武汉大学人民医院生殖医学中心,430060 [3]华中科技大学同济医学院生殖健康研究所,武汉430030

出　　处：《中华生殖与避孕杂志》2020年第3期177-181,共5页Chinese Journal of Reproduction and Contraception

摘　　要：本文旨在探讨新型冠状病毒肺炎(COVID-19)疫情下,病毒感染、治疗药物、环境消毒剂以及由此产生的各类心理问题等对人们生殖系统及功能的潜在影响或危害。通过对既往及最新研究进行文献综述可知,COVID-19可能对两性生殖系统存在潜在影响;在抗病毒治疗期间及治疗结束后至少8个月内建议避孕,但尚无证据支持早孕期在无医学指征的情况下终止妊娠;辅助生殖实验室不建议采用含氯消毒液消毒。医务工作者应该根据患者的生育需求、疾病状况和心理状态进行综合评估,以便给予合理的生育指导和咨询。During the outbreak of COVID-19,this paper aimed to discuss its potential risks on reproductive health,which was underpinned by the virus,drugs,disinfectants and psychological problems.The literatures review on previous and latest studies showed that COVID-19 may have potential effects on both men’s and women’s reproductive systems;that contraception should be recommended during antiviral treatment and for at least eight months after the end of antiviral treatment,but there is no evidence to support the termination of pregnancy without medical indicators during early pregnancy;and that chlorine disinfectants are not recommended for assisted reproduction laboratories.Medical professionals should make a comprehensive assessment according to the patient’s fertility needs,disease status and psychological level,in order to provide reasonable fertility guidance and counselling.

关 键 词：新型冠状病毒肺炎 传染病 生殖健康 

分 类 号：R5[医药卫生—内科学]